Ketoconazole inhibits the cellular uptake of anandamide via inhibition of FAAH at pharmacologically relevant concentrations.
The antifungal compound ketoconazole has, in addition to its ability to interfere with fungal ergosterol synthesis, effects upon other enzymes including human CYP3A4, CYP17, lipoxygenase and thromboxane synthetase. In the present study, we have investigated whether ketoconazole affects the cellular...
Main Authors: | Emmelie Björklund, Therése N L Larsson, Stig O P Jacobsson, Christopher J Fowler |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3900727?pdf=render |
Similar Items
-
Role of FAAH-like anandamide transporter in anandamide inactivation.
by: Kwannok Leung, et al.
Published: (2013-01-01) -
Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
by: Katarzyna Starowicz, et al.
Published: (2013-01-01) -
Involvement of fatty acid amide hydrolase and fatty acid binding protein 5 in the uptake of anandamide by cell lines with different levels of fatty acid amide hydrolase expression: a pharmacological study.
by: Emmelie Björklund, et al.
Published: (2014-01-01) -
The cellular processing of the endocannabinoid anandamide and its pharmacological manipulation
by: Thors, Lina
Published: (2009) -
Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry
by: Allan Weber, et al.
Published: (2004-04-01)